Vitamin K Market: Global Industry Analysis and Forecast (2024-2030)

  • The Vitamin K Market size was valued at USD 925.01 Mn. in 2023 and the total Vitamin K Market size is expected to grow at a CAGR of 7.48% from 2024 to 2030, reaching nearly USD 1532.64 Mn. by 2030.

  • Format : PDF | Report ID : SMR_2188

Vitamin K Market Overview

The Vitamin K market is a global industry that produces, distributes, and consumes vitamin K products, which are essential for blood clotting, bone health, and cardiovascular health. Vitamin K is found in two forms phytonadione found in green leafy vegetables and plant-based foods, and menaquinone found in animal-based foods and gut bacteria. It is commonly used for treating vitamin K deficiency, reversing warfarin's blood-thinning effects, and supporting bone health. The market includes dietary supplements, fortified foods, pharmaceutical formulations, and medical applications. The growing awareness of Vitamin K's importance in maintaining bone health is expected to drive market growth.


The increasing prevalence of chronic diseases like osteoporosis, blood coagulation, arthritis, diabetes, cardiovascular disease, and skin-related diseases is expected to drive market growth size. Consumption of Vitamin K in sufficient amounts helps prevent several diseases. The geriatric population and the trend of preventive healthcare are projected to create significant growth opportunities for the Vitamin K market.

Vitamin K Market


To get more Insights: Request Free Sample Report


Vitamin K Market Dynamics:

The vitamin K market is expected to grow because of the increasing prevalence of chronic disorders, such as hemorrhagic disease in newborns, neonatal bleeding, osteoporosis, arthritis, diabetes, and cardiovascular disease. Infants and newborns are more susceptible to vitamin K deficiencies, leading to increased demand for vitamin K tablets, supplements, or injections. Consumer awareness about the importance of vitamins and minerals, such as Vitamin K, is increasing, leading to heightened demand for products containing Vitamin K. Awareness campaigns and media coverage highlighting the role of Vitamin K in preventing bone fractures and cardiovascular issues contribute to market growth.


The global Vitamin K market is growing because of increased awareness of its health benefits, especially in bone and cardiovascular health. Consumer demand for dietary supplements and functional foods enriched with Vitamin K is expected to continue. Innovations in product formulations and growing applications in cosmetics and pharmaceuticals contribute to market growth.


Government frameworks mandate the fortification of food products with essential nutrients, including Vitamin K. Compliance with these morals improves consumer confidence in fortified foods and creates a constant demand for Vitamin K among food producers. This trend towards proactive health management is raising market growth and a shift towards proactive health management among consumers.


North America is experiencing prominent developments in regulations and consumer preferences towards Vitamin K-enriched products, with a growing trend towards natural and organic sources. Research on Vitamin K's role in immune support and aging-related conditions is also driving interest in the market.

Vitamin K Market1

The vitamin K market faces several challenges, such as low consumer awareness about its importance for overall health, varying regulatory environments across industries, the high cost of extracting and packing vitamin K formulations, and its health benefits Ongoing scientific research on the topic and resulting competition other micronutrient supplements and foods complicate market positioning and consumer education efforts. Concerted efforts in research, education, regulation, and market growth strategies are essential to unlock the full potential of the vitamin K market. The regulatory framework varies from region to region, and ongoing scientific research into the role of vitamin K2 in heart health and bone metabolism affects consumer confidence and market acceptance.


The Vitamin K market presents several promising opportunities for growth and development. First, demand increases among consumers as awareness of the health benefits of vitamin K, especially vitamin K2, increases. Research is producing this trend that shows its role in bone health, cardiovascular health, and other potential areas such as cognitive function. Advances in technology and manufacturing processes increase the efficiency and scalability of the production processes for vitamin K and fortified foods thereby reducing costs and expanding the market, especially in areas where food shortages are common.


Regulatory support for dietary supplements and enforcement programs in different countries promote market growth opportunities. Governments and health organizations recognize the importance of vitamin K and other micronutrients in public health, resulting in variable policies and guidelines Also, partnerships and collaborations among key players in the pharmaceutical, nutraceutical, and food industries support innovation and product development, leading to the development of new formulations and delivery methods to cater to diverse customers which they want to address. All these factors contribute to the promising outlook of the Vitamin K market globally.


Vitamin K Market Segment Analysis:

Based on Application, the osteoporosis segment dominated the vitamin K market, as it plays a crucial role in bone metabolism and mineralization, reducing fracture risk. This condition is primarily affecting older adults, particularly postmenopausal women and elderly individuals, who are at higher risk of bone-related complications. As the global population ages, the prevalence of osteoporosis is expected to rise, driving demand for interventions supporting bone health, including vitamin K supplements.


The dermal application segment also held a significant share of the vitamin K market, with numerous skin applications including resolving bruising, suppressing pigmentation, limiting acneiform side effects, and aiding in wound healing. Vitamin K is non-irritating and safe for all skin types, and it improves wound healing by increasing contraction and assisting in collagen and blood vessel formation. Its redox properties allow the skin to detoxify reactive oxygen species formed from exposure to UV rays and pollution.


Vitamin K Market Regional Insight:

North American vitamin K market, which dominated the market in 2023, driven by factors such as prominent manufacturers, a growing geriatric population, awareness of nutritional benefits, investment in research, demand for injectables, and the prevalence of chronic disorders like neonatal bleeding, arthritis, cancer, diabetes, vascular calcification, and osteoporosis. The region's established market of dietary supplements and fortified foods is also fueled by high healthcare expenditure and individuals willing to invest in preventive measures. The rising frequency of vitamin K-related disorders, such as newborn hemorrhage, osteoporosis, and vascular calcification, is positively impacting the industry's growth. Sedentary lifestyles, poor dietary habits, and lack of exercise are activating risk factors associated with these diseases, further boosting regional growth.


  • The U.S. market is experiencing significant growth because of increasing demand for nutritional products, advanced healthcare infrastructure, wellness focus, vitamin K-related disorders, and innovative product development.


Vitamin K Market2

Vitamin K Market Competitive Landscape:

  • 24 Jun 2024, dsm-firmenich, the leading innovator in health, nutrition, and beauty has recently launched a shrimp module for Sustell™, allowing shrimp farmers to map, reduce the full environmental footprint of their operations and meet environmental sustainability targets.


  • In 2024, Lonza is closing manufacturing facilities in Guangzhou, China, and Hayward, California. The closures are begin in Q1 2024 and be completed by early 2025. The company reported an impairment loss of $2.12 million combined with $58 million in restructuring costs.

Vitamin K Market Scope

Market Size in 2023

USD 925.01 Mn.

Market Size in 2030

USD 1532.64 Mn.

CAGR (2024-2030)

7.48 %

Historic Data


Base Year


Forecast Period



By Product Type

Vitamin K1

Vitamin K2

By Route of Administration




By Application


Vitamin K Dependent Clotting Factor Deficiency (VKCFD)

Prothrombin deficiency

Vitamin K Deficiency Bleeding (VKDB)

Dermal Application


Regional Scope

North America- United States, Canada, and Mexico

Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe

Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC

Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa

South America – Brazil, Argentina, Rest of South America


Key Player in the Vitamin K Market        

  1. BASF SE - Germany
  2. Lonza Group - Switzerland
  3. SternVitamin GmbH & Co. K.G. - Germany
  4. Adisseo - France
  5. DSM - Netherlands
  6. Kappa Bioscience - Norway
  7. Livealth Biopharma - India
  8. Amphastar Pharmaceuticals Inc. - United States
  9. NOW Foods - United States
  10. Pfizer Inc - United States
  11. Solgar Inc - United States
  12. Kyowa Hakko USA - United States
  13. Atlantic Essential Products Inc. - Canada
  14. Bactolac Pharmaceutical Inc. - United States
  15. Glanbia Plc - Ireland
  16. ADM (Archer Daniels Midland) - United States
  17. Farbest Brands - United States
  18. BTSA Biotechnologias Aplicadas S.L. - Spain
  19. Rabar Pty Ltd - Australia
  20. Viridis BioPharma - United States

Frequently Asked Questions

The forecast period of the market is 2024 to 2030.

1.    Vitamin K Market: Research Methodology 
2.    Vitamin K Market: Executive Summary
3.    Vitamin K Market: Competitive Landscape
4.    Potential Areas for Investment

4.1. Stellar Competition Matrix
4.2. Competitive Landscape
4.3. Key Players Benchmarking
4.4. Market Structure
4.4.1.    Market Leaders 
4.4.2.    Market Followers
4.4.3.    Emerging Players

4.5. Consolidation of the Market
4.6. Import and export of Vitamin K Market 
5.    Vitamin K Market : Dynamics
5.1. Market Driver 
5.1.1.    Increasing Consumer Awareness
5.1.2.    Innovation in Product Offerings

5.2. Market Trends by Region
5.2.1.    North America
5.2.2.    Europe
5.2.3.    Asia Pacific
5.2.4.    Middle East and Africa
5.2.5.    South America

5.3. Market Drivers by Region
5.3.1.    North America
5.3.2.    Europe
5.3.3.    Asia Pacific
5.3.4.    Middle East and Africa
5.3.5.    South America

5.4. Market Restraints
5.5. Market Opportunities
5.6. Market Challenges
5.7. PORTER’s Five Forces Analysis
5.8. PESTLE Analysis
5.9. Strategies for New Entrants to Penetrate the Market
5.10. Regulatory Landscape by Region
5.10.1.    North America
5.10.2.    Europe
5.10.3.    Asia Pacific
5.10.4.    Middle East and Africa
5.10.5.    South America

6.    Vitamin K Market Size and Forecast by Segments (by value Units)
6.1. Vitamin K Market Size and Forecast, by Product Type (2023-2030)
6.1.1.    Vitamin K1
6.1.2.    Vitamin K2

6.2. Vitamin K Market Size and Forecast, by Route of Administration  (2023-2030)
6.2.1.    Oral
6.2.2.    Topical
6.2.3.    Parenteral

6.3. Vitamin K Market Size and Forecast, by Application (2023-2030)
6.3.1.    Osteoporosis
6.3.2.    Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
6.3.3.    Prothrombin deficiency
6.3.4.    Vitamin K Deficiency Bleeding (VKDB)
6.3.5.    Dermal Application
6.3.6.    Others

6.4. Vitamin K Market Size and Forecast, by Region (2023-2030)
6.4.1.    North America
6.4.2.    Europe
6.4.3.    Asia Pacific
6.4.4.    Middle East and Africa
6.4.5.    South America

7.    North America Vitamin K Market Size and Forecast (by value Units)
7.1. North America Vitamin K Market Size and Forecast, by Product Type (2023-2030)
7.1.1.    Vitamin K1
7.1.2.    Vitamin K2

7.2. North America Vitamin K Market Size and Forecast, by Route of Administration  (2023-2030)
7.2.1.    Oral
7.2.2.    Topical
7.2.3.    Parenteral

7.3. North America Vitamin K Market Size and Forecast, by Application (2023-2030)
7.3.1.    Osteoporosis
7.3.2.    Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
7.3.3.    Prothrombin deficiency
7.3.4.    Vitamin K Deficiency Bleeding (VKDB)
7.3.5.    Dermal Application
7.3.6.    Others

7.4. North America Vitamin K Market Size and Forecast, by Country (2023-2030)
7.4.1.    United States
7.4.2.    Canada
7.4.3.    Mexico

8.    Europe Vitamin K Market Size and Forecast (by Value Units)
8.1. Europe Vitamin K Market Size and Forecast, by Product Type (2023-2030)
8.1.1.    Vitamin K1
8.1.2.    Vitamin K2

8.2. Europe Vitamin K Market Size and Forecast, by Route of Administration  (2023-2030)
8.2.1.    Oral
8.2.2.    Topical
8.2.3.    Parenteral

8.3. Europe Vitamin K Market Size and Forecast, by Application (2023-2030)
8.3.1.    Osteoporosis
8.3.2.    Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
8.3.3.    Prothrombin deficiency
8.3.4.    Vitamin K Deficiency Bleeding (VKDB)
8.3.5.    Dermal Application
8.3.6.    Others

8.4. Europe Vitamin K Market Size and Forecast, by Country (2023-2030)
8.4.1.    UK
8.4.2.    France
8.4.3.    Germany
8.4.4.    Italy
8.4.5.    Spain
8.4.6.    Sweden
8.4.7.    Austria
8.4.8.    Rest of Europe

9.    Asia Pacific Vitamin K Market Size and Forecast (by Value Units)
9.1. Asia Pacific Vitamin K Market Size and Forecast, by Product Type (2023-2030)
9.1.1.    Vitamin K1
9.1.2.    Vitamin K2

9.2. Asia Pacific Vitamin K Market Size and Forecast, by Route of Administration  (2023-2030)
9.2.1.    Oral
9.2.2.    Topical
9.2.3.    Parenteral

9.3. Asia Pacific Vitamin K Market Size and Forecast, by Application (2023-2030)
9.3.1.    Osteoporosis
9.3.2.    Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
9.3.3.    Prothrombin deficiency
9.3.4.    Vitamin K Deficiency Bleeding (VKDB)
9.3.5.    Dermal Application
9.3.6.    Others

9.4. Asia Pacific Vitamin K Market Size and Forecast, by Country (2023-2030)
9.4.1.    China
9.4.2.    S Korea
9.4.3.    Japan
9.4.4.    India
9.4.5.    Australia
9.4.6.    Asean
9.4.7.    Rest of Asia Pacific

10.    Middle East and Africa Vitamin K Market Size and Forecast (by Value Units)
10.1. Middle East and Africa Vitamin K Market Size and Forecast, by Product Type (2023-2030)
10.1.1.    Vitamin K1
10.1.2.    Vitamin K2

10.2. Middle East and Africa Vitamin K Market Size and Forecast, by Route of Administration  (2023-2030)
10.2.1.    Oral
10.2.2.    Topical
10.2.3.    Parenteral

10.3. Middle East and Africa Vitamin K Market Size and Forecast, by Application (2023-2030)
10.3.1.    Osteoporosis
10.3.2.    Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
10.3.3.    Prothrombin deficiency
10.3.4.    Vitamin K Deficiency Bleeding (VKDB)
10.3.5.    Dermal Application
10.3.6.    Others

10.4. Middle East and Africa Vitamin K Market Size and Forecast, by Country (2023-2030)
10.4.1.    South Africa
10.4.2.    GCC
10.4.3.    Rest of ME&A

11.    South America Vitamin K Market Size and Forecast (by Value Units)
11.1. South America Vitamin K Market Size and Forecast, by Product Type  (2023-2030)
11.1.1.    Vitamin K1
11.1.2.    Vitamin K2

11.2. South America Vitamin K Market Size and Forecast, by Route of Administration  (2023-2030)
11.2.1.    Oral
11.2.2.    Topical
11.2.3.    Parenteral

11.3. South America Vitamin K Market Size and Forecast, by Application (2023-2030)
11.3.1.    Osteoporosis
11.3.2.    Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
11.3.3.    Prothrombin deficiency
11.3.4.    Vitamin K Deficiency Bleeding (VKDB)
11.3.5.    Dermal Application
11.3.6.    Others

11.4. South America Vitamin K Market Size and Forecast, by Country (2023-2030)
11.4.1.    Brazil
11.4.2.    Argentina
11.4.3.    Rest of South America

12.    Company Profile: Key players
12.1.  BASF SE
12.1.1.    Company Overview
12.1.2.    Financial Overview
12.1.3.    Business Portfolio
12.1.4.    SWOT Analysis
12.1.5.    Business Strategy 
12.1.6.    Recent Developments

12.2. Lonza Group
12.3. SternVitamin GmbH & Co. K.G.
12.4. Adisseo
12.5. DSM
12.6. Kappa Bioscience
12.7. Livealth Biopharma
12.8. Amphastar Pharmaceuticals Inc.
12.9. NOW Foods
12.10. Pfizer Inc    
12.11. Solgar Inc n 
12.12. Kyowa Hakko USA
12.13. Atlantic Essential Products Inc.
12.14. Bactolac Pharmaceutical Inc.
12.15. Glanbia Plc 
12.16. ADM 
12.17. Farbest Brands 
12.18. BTSA Biotechnologias Aplicadas S.L. 
12.19. Rabar Pty Ltd 
12.20. Viridis BioPharma 
13.    Key Findings
14.    Industry Recommendation

Enquiry Before Buy

Request Sample PDF